2 transcripts
Earnings call transcript
2024 Q1
2 May 24
that's also a factor that we consider. But overall, we've done what we think to engineer peripheral cytokine activation, that's independent of tumor
Earnings call transcript
2023 Q4
6 Mar 24
balancing what was very important for us in the design of this molecule was balancing the potential for any sort of T cell activation independent
- Prev
- 1
- Next